Discovery of novel α-amylase inhibitors using structure-based drug design

被引：0
|
作者：
Jamil Al-Asri
Gerhard Wolber
机构：
[1] Freie Universität Berlin,Computer
来源：
Journal of Cheminformatics | / 6卷 / Suppl 1期
关键词：
Molecular Docking; Virtual Screening; Pharmacophore Model; Secondary Plant Metabolite; Glycoside Hydrolase Family;
D O I：
10.1186/1758-2946-6-S1-P50
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [21] Recent Advances in the Structure-Based Drug Design and Discovery
    Hassan, Md. Imtaiyaz
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (09) : 899 - 900
  • [22] Advances in structure-based drug discovery of carbonic anhydrase inhibitors
    Supuran, Claudiu T.
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (01) : 61 - 88
  • [23] Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening
    Kumar, Rajnish
    Kumar, Amit
    Langstrom, Bengt
    Darreh-Shori, Taher
    SCIENTIFIC REPORTS, 2017, 7
  • [24] Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening
    Rajnish Kumar
    Amit Kumar
    Bengt Långström
    Taher Darreh-Shori
    Scientific Reports, 7
  • [25] Structure-based drug design of novel urokinase plasminogen activator inhibitors.
    Subasinghe, N
    Hoffman, J
    Rudolph, J
    Soll, R
    Wilson, K
    Randle, T
    Green, D
    Lewandowski, F
    Zhang, M
    Bone, R
    Spurlino, J
    Deckman, I
    Manthey, C
    Zhou, Z
    Sharp, C
    Kratz, D
    Grasberger, B
    DesJarlais, R
    Molloy, CJ
    Illig, C
    CLINICAL CANCER RESEARCH, 1999, 5 : 3841S - 3841S
  • [26] Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design
    Fujimori, Ikuo
    Wakabayashi, Takeshi
    Murakami, Morio
    Okabe, Atsutoshi
    Ishii, Tsuyoshi
    McGrath, Aaron
    Zou, Hua
    Saikatendu, Kumar Singh
    Imoto, Hiroshi
    ACS OMEGA, 2020, 5 (49): : 31984 - 32001
  • [27] Oxyguanidines: Discovery of novel orally active thrombin inhibitors through structure-based drug design and parallel synthesis.
    Markotan, TP
    Lu, TB
    Coppo, F
    Tomczuk, BE
    Crysler, C
    Eisennagel, S
    Spurlino, J
    Soll, RM
    Bone, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U16 - U16
  • [28] Structure-based drug design of pyruvate kinase inhibitors
    Maxwell, David S.
    Peng, Zhenghong
    Sun, Duoli
    Yung, W. K. Alfred
    Lu, Zhimin
    Bornmann, William G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [29] Structure-Based Drug Discovery for Prion Disease Using a Novel Binding Simulation
    Ishibashi, Daisuke
    Nakagaki, Takehiro
    Ishikawa, Takeshi
    Atarashi, Ryuichiro
    Watanabe, Ken
    Cruz, Felipe A.
    Hamada, Tsuyoshi
    Nishida, Noriyuki
    EBIOMEDICINE, 2016, 9 : 238 - 249
  • [30] Structure-based discovery of novel influenza neuraminidase inhibitors.
    Stewart, KD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U39 - U39
12345